resources

CCME Global Ltd.

BSE: 514336

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Biotechnology

123.50+2.7 (+2.28%)

8 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

CCME Global Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Jun Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

CCME Global Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under R. 74(5) of SEBI DP Regulations for the quarter ended on June 30, 2026.
Closure of Trading Window25 Jun 2026
Closure of Trading Window
Closure of trading window for the purpose of unaudited financial results for the first quarter of FY 2026 - 2027 ending on June 30, 2026.
Change in Management23 Jun 2026
Announcement under Regulation 30 (LODR)-Change in Management
Intimation for resignation of statutory auditors of the Company.
Resignation of Statutory Auditors23 Jun 2026
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Intimation for resignation of statutory auditors of the Company.
Reg.24(A)-Annual Secretarial Compliance30 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Compliance Audit Report for the financial year ended March 31, 2026
Reg. 32 (1), (3) - Statement of Deviation & Variation29 May 2026
Statement Of Deviation For The Quarter And Financial Year Ended March 31, 2026
Statement of deviation for the quarter and financial year ended March 31, 2026
Outcome of Board Meeting29 May 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On May 29, 2026
Outcome of board meeting held on May 29, 2026.
Board Meeting22 May 2026
Board Meeting Intimation for Intimation Of The Board Meeting To Be Held On May 29, 2026 To Consider And Approve Financial Results For The Quarter And Financial Year Ended March 31, 2026 And Other Matters
CCME Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Intimation of the board meeting ....
General30 Apr 2026
Intimation About Receipt Of Listing Approval For 32250000 Equity Shares Allotted On March 26, 2026
Intimation about receipt of listing approval for 32250000 equity shares allotted on March 26, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A17 Apr 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....
Change in Management8 Apr 2026
Announcement under Regulation 30 (LODR)-Change in Management
Company Secretary designated as Key Managerial Personnel.
Change in Corporate Office Address8 Apr 2026
Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
Situation of corporate office and keeping books of accounts at the office other than registered office.
Appointment of Company Secretary / Compliance Officer8 Apr 2026
Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary, Compliance Officer and KMP.
Outcome without intimation8 Apr 2026
Board Meeting Outcome for Outcome Of Board Meeting For Appointment Of Company Secretary, Compliance Officer And KMP. Also For Situation Of Corporate Office And Keeping Books Of Accounts At The Place Other Than Registered Office.
Outcome of board meeting for appointment of Company Secretary, Compliance Officer and KMP. Also for situation of corporate office and keeping books of accounts at the place other than the ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate for the quarter ended on March 31, 2026.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201130 Mar 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for V Varalakshmi
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201130 Mar 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padmanaban Krishnamoorthy
Allotment of Equity Shares26 Mar 2026
Announcement under Regulation 30 (LODR)-Allotment
Intimation for allotment of equity shares which were issued on preferential basis.
Closure of Trading Window26 Mar 2026
Closure of Trading Window
Closure of trading window for the fourth quarter and financial year ended on March 31, 2026
General13 Mar 2026
The Company Has Received In-Principle Approval From BSE Limited For Issue Of Equity Shares On Preferential Basis.
The Company has received in-principle approval from BSE Limited for issue of equity shares to promoters and non-promoters on preferential basis.

Frequently Asked Questions

Where can I download the annual report of CCME Global Ltd.?

Annual reports of CCME Global Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of CCME Global Ltd.?

Quarterly earnings results and presentations of CCME Global Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does CCME Global Ltd. publish earnings call transcripts?

Earnings call transcripts of CCME Global Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of CCME Global Ltd.?

Investor presentations and annual day presentations of CCME Global Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of CCME Global Ltd.?

Corporate announcements and regulatory filings of CCME Global Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of CCME Global Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of CCME Global Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of CCME Global Ltd.?

The ISIN (International Securities Identification Number) of CCME Global Ltd. is INE194N01016. This is the unique identifier used across exchanges and depositories.

On which stock exchange is CCME Global Ltd. listed?

CCME Global Ltd. is listed on NSE and BSE. The NSE symbol is GENESIS and the BSE code is -.

Where can I find the shareholding pattern of CCME Global Ltd.?

The quarterly shareholding pattern of CCME Global Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for CCME Global Ltd. on Sharpely?

Share price data for CCME Global Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.